These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 11806400)

  • 1. Does radiotherapy have a role in the management of thyroid orbitopathy? Comment.
    McNab AA
    Br J Ophthalmol; 2002 Jan; 86(1):106-7. PubMed ID: 11806400
    [No Abstract]   [Full Text] [Related]  

  • 2. [Complications during systemic corticosteroid therapy combined with orbital radiotherapy in patients with graves orbitopathy].
    Kulig G; Kaźmierczyk-Puchalska A; Krzyzanowska-Swiniarska B; Pilarska K
    Przegl Lek; 2004; 61(8):855-6. PubMed ID: 15789916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effectiveness of treatment for thyroid orbitopathy in patients hospitalized at the Endocrinology Department of Pomeranian Medical University].
    Kulig G; Kaźmierczyk-Puchalska A; Krzyzanowska-Swiniarska B; Pilarska K
    Przegl Lek; 2004; 61(8):852-4. PubMed ID: 15789915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Results of treatment of endocrine orbitopathy].
    Eitel B; Schroeter M; Gnensch S; Schminke S
    Z Gesamte Inn Med; 1989 Jan; 44(1):22-5. PubMed ID: 2711713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [New therapeutic manual of malignant exophthalmos].
    Izumi M; Nagataki S
    Nihon Naibunpi Gakkai Zasshi; 1991; 67 Suppl 1():112-20. PubMed ID: 2044825
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of Graves' ophthalmopathy with oral or intravenous corticosteroids].
    Brauer VF; Scholz GH
    Med Klin (Munich); 2004 Feb; 99(2):71-6. PubMed ID: 14963657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Graves' ophthalmopathy: diagnosis and highlights on etiopathogenesis and treatment].
    Kamoun M; Abid H; Lamine F; Slimane H; Haddad A
    Tunis Med; 2003 Mar; 81(3):149-55. PubMed ID: 12793063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does radiotherapy have a role in the management of thyroid orbitopathy? View 2.
    Mourits MP
    Br J Ophthalmol; 2002 Jan; 86(1):104-6. PubMed ID: 11806399
    [No Abstract]   [Full Text] [Related]  

  • 9. Results and prognostic factors in retrobulbar radiotherapy combined with systemic corticosteroids for endocrine orbitopathy (Graves' disease).
    Staar S; Müller RP; Hammer M; Nolte M
    Front Radiat Ther Oncol; 1997; 30():206-17. PubMed ID: 9205903
    [No Abstract]   [Full Text] [Related]  

  • 10. Restoration of vision by radiotherapy for severe, acute, steroid-refractory, congestive thyroid orbitopathy.
    MacAndie K; Harnett AN; Kyle P
    Clin Oncol (R Coll Radiol); 2000; 12(3):188-91. PubMed ID: 10942337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical results of anti-inflammatory therapy in Graves' ophthalmopathy and association with thyroidal autoantibodies.
    Eckstein AK; Plicht M; Lax H; Hirche H; Quadbeck B; Mann K; Steuhl KP; Esser J; Morgenthaler NG
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):612-8. PubMed ID: 15521965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Medical treatment of dysthyroid orbitopathy].
    Badelon I; Morax S
    J Fr Ophtalmol; 2004 Sep; 27(7):822-4. PubMed ID: 15499285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Administration of additional inactive iodide during radioiodine therapy for Graves' disease: who might benefit?
    Dietlein M; Moka D; Reinholz U; Schmidt M; Schomäcker K; Schicha H; Wellner U
    Nuklearmedizin; 2007; 46(3):77-84. PubMed ID: 17549318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do glucocorticoids affect outcome in Graves' disease following radioiodine therapy?
    Salvatore D; Fenzi G
    Nat Clin Pract Endocrinol Metab; 2006 Apr; 2(4):194-5. PubMed ID: 16932282
    [No Abstract]   [Full Text] [Related]  

  • 15. Oral pentoxifylline and topical clobetasol propionate ointment in the treatment of pretibial myxoedema, with concomitant improvement of Graves' ophthalmopathy.
    Pineda AM; Tianco EA; Tan JB; Casintahan FA; Beloso MB
    J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1441-3. PubMed ID: 17958873
    [No Abstract]   [Full Text] [Related]  

  • 16. [Evaluation of radioiodine 131I treatment in Graves' disease patients with mild orbitopathy].
    Bałdys-Waligórska A; Stefańska A; Gołkowski F; Sokołowski G; Hubalewska-Dydejczyk A
    Przegl Lek; 2009; 66(4):166-9. PubMed ID: 19708504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Radiotherapy of endocrine orbitopathy--state of the art].
    Prettenhofer U; Ramschak-Schwarzer S; Langmann A; Mayer R; Schedlbauer P; Hackl A
    Acta Med Austriaca; 2001; 28(4):97-8. PubMed ID: 11593899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Quantitative results following consecutive corticoid and radiotherapy in endocrine ophthalmopathy].
    Esser J; Molls M; Benker G
    Fortschr Ophthalmol; 1988; 85(3):323-6. PubMed ID: 3209166
    [No Abstract]   [Full Text] [Related]  

  • 19. [Retrobulbar irradiation for Graves' ophthalmopathy -- long-term results].
    Pitz S; Kahaly G; Rösler HP; Krummenauer F; Wagner B; Stübler M; Pfeiffer N
    Klin Monbl Augenheilkd; 2002 Dec; 219(12):876-82. PubMed ID: 12548473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Graves' orbitopathy].
    Balázs C
    Orv Hetil; 2006 Jun; 147(22):1011-7. PubMed ID: 16913090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.